In April 2021, quality-control problems were discovered in the production of Johnson & Johnson Covid-19 vaccines at a Baltimore plant owned by Emergent BioSolutions. Out of precaution, health officials on three continents - Europe, South Africa, and North America - decided to pause the distribution of millions of Johnson & Johnson doses. (1.5 points) Consider the risk described in this event and answer the following by filling in the blank next to each question. 1. Is the risk pure or speculative risk? (Choose ONE) 2. Is the risk diversifiable or non-diversifiable risk? (Choose ONE) 3. Which ERM risk category does the risk belongs to? (Choose ONE)